Through the integration of multidisciplinary approaches within medicinal chemistry and nanobiotechnology, Nanomater can design and build nanoparticles for "Active Targeting", with programmable features, in order enhance site-specificity towards different biological targets, as well as to increase the therapeutic efficacy and the bioavailability of active molecules.
​
The nanoparticle surface can be functionalized with specific ligands (antibodies, peptides, aptamers or small organic molecules), which allow to increase the plasma half-life, reduce immunogenicity and favor the targeting toward surface proteins overexpressed on target cells.
​
Nanomater can encapsulate molecules provided by the client and engineer or functionalize the nanoparticles according to specific requests

R&D OF TARGETED NANOPARTICLES

-structure-based design of ligand for targeting
​
-polymer functionalization with ligand

-targeted nanoparticles formulation
​
-nanoparticles characterization

-in vitro dissolution test
​
- In vitro stability test
​

-in vitro biocompatibility test
​
- In vitro cytotoxicity test
​